Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Krzysztof Piotrowski

Krzysztof Piotrowski

DIAGEN co., Poland

Title: The genetic aspect of human heart development based on prenatal diagnosis

Biography

Biography: Krzysztof Piotrowski

Abstract

Congenital heart diseases (CHD) are the most common malformations both as an isolated form and a part of genetic syndromes. Extraordinarily fast development of molecular genetics confirms that almost all CHD are genetically dependent in terms of microaberrations in diff erent regions of a chromosome or single gene mutations. On the other hand, CHD are an important component of diverse genetic diseases, including monogenic, metabolic and mitochondrial disorders, most oft en as secondary cardiomyopathies. The genes participating therein are located nearly on each chromosome, mainly on pathways, along with ligand genes and co-factors, transcription factors or individually. Many mechanisms on heart development are based on the balance between apoptosis, proliferation and migration. Crucial genes controlling fetal development, including the creation of heart tube and the forming of left  and right ventricular outflow is primary “homeobox” genes grouped in 4 clusters hox1-4. Other genes condition the forming of different structures. The key process for activating consecutive genes is methylation. Methyl groups originate from the metabolic cycle of folic acid, where the main gene is MTHFR. Moreover, in numerous functional disorders, for example the Arrhythmia or block, the reason is also genetic, namely the mutation of ion-channel gene placed in 6 chromosomes. Now we have over 1500 mutations. Many genes of cardiogenesis were identified, thanks to the investigations of other genetic disorders, for example: PTPN11 gene in Noonan syndrome. The gene is also responsible for the development of pulmonary valves. TBX5 gene in Holt-Oram syndrome. Presently the most promising method is NGS technology, where we can perform hundreds of mutations at a time. Heart development is also affected by the imprinting (about 30 genes) and the inactivation of the X chromosome in day 21 stage of embryo. We propose, for e.g. a practical classifi cation could refer to specifi c CHD characteristic of particular disorders, which might prove helpful in daily practice because in prenatal diagnosis CHD is oft en the sole syndrome confi rmed by USG scan, which may depend on truly isolated nature or non-specific mild ultrasound co-markers.